Quantifying the competitiveness of the electronic health record market and its implications for interoperability.

EHR Market competitiveness Electronic medical records Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH) Interoperability Meaningful use

Journal

International journal of medical informatics
ISSN: 1872-8243
Titre abrégé: Int J Med Inform
Pays: Ireland
ID NLM: 9711057

Informations de publication

Date de publication:
04 2020
Historique:
received: 18 09 2019
revised: 11 11 2019
accepted: 25 11 2019
pubmed: 31 1 2020
medline: 29 7 2020
entrez: 31 1 2020
Statut: ppublish

Résumé

The objective of this study was to quantify both the competitiveness of the EHR vendor market in the United States of America (US) and the degree of fragmentation of individual Medicare beneficiaries' medical records across the differing EHR vendors found in the US healthcare system. We determined the Part A and Part B Medicare-expenditure weighted market shares of EHR vendors and estimated the rate of attestation of meaningful use (MU) for EHRs among Medicare Part A & B providers from 2011 to 2016. Based on these data we calculated the annual Herfindahl-Hirschman Index to quantify the competitiveness of the EHR market as well as the number of vendors individual Medicare beneficiaries' medical records were stored in for the period 2014-2016. We find that as of 2016 the EHR vendor environment was competitive but trending towards becoming highly concentrated soon. We also found that patient medical records were highly fragmented as only 4.5 % of expenditure-weighted individual Medicare beneficiaries had their MU medical records associated with a single vendor, while 19.8 % of expenditure-weighted beneficiaries had their MU medical records stored in 8 or more vendors. These results indicate that there are tradeoffs between EHR market competition, and the challenges associated with achieving interoperability across numerous competing vendors. Uncertainty of interoperability among different EHR vendors may make transmission of medical records among different providers challenging, mitigating the benefit of vendor competition. This highlights the critical importance of current interoperability efforts moving forward.

Identifiants

pubmed: 32000012
pii: S1386-5056(19)31013-5
doi: 10.1016/j.ijmedinf.2019.104037
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

104037

Informations de copyright

Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no competing interests to declare.

Auteurs

James Sorace (J)

Retired from Division of Data Policy, Office of Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, 8620 Valleyfield Road Lutherville, MD 21093, USA. Electronic address: jamessorace1@gmail.com.

Hui-Hsing Wong (HH)

Division of Science Policy, Office of Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington DC, USA.

Thomas DeLeire (T)

Georgetown University and at Acumen, LLC, Washington DC, USA.

Dashi Xu (D)

Acumen, LLC, Washington DC, USA.

Sheila Handler (S)

Acumen, LLC, Washington DC, USA.

Bruno Garcia (B)

Acumen, LLC, Washington DC, USA.

Thomas MaCurdy (T)

Stanford University at Acumen, LLC, Burlingame, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH